Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Compound 49b shows promise to treat diabetic retinopathy

May 10, 2011

European phase III Diamyd trial in type 1 diabetes does not meet primary endpoint

May 9, 2011

Dainippon Sumitomo Pharma sets Japanese launch date for Surepost

May 9, 2011

Zafgen claims novel methionine aminopeptidase 2 inhibitors

May 9, 2011

Pfizer discovers potent and selective inhibitors of phosphodiesterase 8B

May 9, 2011

Santaris Pharma advances SPC-5001 to phase I for hypercholesterolemia

May 6, 2011

Savient Pharmaceuticals files MAA with the EMA for Krystexxa in chronic gout

May 5, 2011

Novel estrogen receptor beta ligands prepared at Karo Bio

May 5, 2011

Karo Bio synthesizes new estrogen receptor-beta ligands

May 4, 2011

Jenrin Discovery presents new cannabinoid CB1 receptor antagonists/inverse agonists

May 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...